Revolution Medicines, Inc. (RVMD)
Nasdaq: RVMD · Biological Products, (No Diagnostic Substances) · Redwood City, CA · filing with the SEC since 2016
Who runs Revolution Medicines, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Goldsmith Mark A
President and Chief Executive Officer. First filing Feb 2020, latest Sep 18, 2026, 44 filings in all.
Officers reporting now
9
of 16 people with a filing in the last fifteen months
Directors reporting now
7
23 people on the record since 2020
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mancini Anthony | See Remarks | Mar 2026 | Nov 12, 2026 | 24 · $10.4M |
| Sandler Alan B. | Chief Development Officer | Mar 2026 | Oct 1, 2026 | 7 · $1.3M |
| Cislini Jeff | SVP & General Counsel | Mar 2023 | Sep 29, 2026 | 15 · $14.6M |
| Goldsmith Mark A | President and Chief Executive Officer | Feb 2020 | Sep 18, 2026 | 42 · $54.1M |
| Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Feb 2020 | Sep 18, 2026 | 13 · $21.3M |
| Anders Jack | Chief Financial Officer | Feb 2020 | Sep 18, 2026 | 11 · $6.5M |
| Horn Margaret A | Chief Operating Officer | Feb 2020 | Sep 18, 2026 | 16 · $25.3M |
| Wei Lin | Chief Medical Officer | Mar 2024 | Mar 19, 2026 | 1 · $200,000 |
| Wang Xiaolin | EVP, Clinical Development | Mar 2021 | Mar 19, 2026 | 1 · $200,000 |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Anderson Elizabeth M | director | Feb 2020 | Sep 24, 2026 | 5 · $2.0M |
| Kim Lorence H. | director | Jul 2022 | Sep 10, 2026 | 14 · $15.0M |
| Patel Sushil | director | Jun 2022 | Jul 1, 2026 | 9 · $1.0M |
| Borellini Flavia | director | Jun 2021 | Jun 23, 2026 | none |
| Borisy Alexis | director | Feb 2020 | Jun 23, 2026 | none |
| Clyburn Frank | director | Aug 2024 | Jun 23, 2026 | none |
| Horning Sandra | director | Nov 2023 | Jun 23, 2026 | none |
Earlier names on the record27, newest filing first
Schroeder Thilo · director · last filing Dec 2024Weber Barbara · director · last filing Oct 2024Schmidt Eric Thomas · director · last filing Jun 2023Exter Neil · director · last filing Jun 2022Tepper Robert I · 10% owner · last filing Jun 2022Third Rock Ventures Gp III, L.P. · 10% owner · last filing Jun 2022Third Rock Ventures III, L.P. · 10% owner · last filing Jun 2022Trv Gp III, LLC · 10% owner · last filing Jun 2022Miller Vincent A. · director · last filing Jun 2021Levin Mark J · 10% owner · last filing Jun 2021Starr Kevin P · 10% owner · last filing Jun 2021Third Rock Ventures Gp II, L.P. · 10% owner · last filing Jun 2021Third Rock Ventures II, L.P. · 10% owner · last filing Jun 2021Trv Gp II, LLC · 10% owner · last filing Jun 2021Svennilson Peter · director · last filing Apr 2021Column Group III Gp, LP · 10% owner · last filing Nov 2020Column Group III-A, LP · 10% owner · last filing Nov 2020Column Group III, LP · 10% owner · last filing Nov 2020Goeddel David V · 10% owner · last filing Nov 2020Kutzkey Tim · 10% owner · last filing Nov 2020Ponoi Capital II, LP · 10% owner · last filing Nov 2020Ponoi Capital, LP · 10% owner · last filing Nov 2020Ponoi II Management, LLC · 10% owner · last filing Nov 2020Ponoi Management, LLC · 10% owner · last filing Nov 2020Deerfield Management Company, L.P. (Series C) · 10% owner · last filing Feb 2020Deerfield Mgmt IV, L.P. · 10% owner · last filing Feb 2020Lasky Laurence · director · last filing Feb 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.